Skip to main content
. 2022 Apr 21;12:6591. doi: 10.1038/s41598-022-10587-0

Table 3.

Comparisons between the low SMI group and normal SMI group.

Low SMI (n = 33) Normal (n = 45) P-value
Male/female 17/16 33/12 0.047
Age (year), mean ± SD 44.0 ± 14.6 41.6 ± 12.6 0.47
BMI (kg/m2), mean ± SD 18.8 ± 2.3 21.6 ± 3.2  < 0.0001
Height (cm), mean ± SD 162.5 ± 8.5 167.8 ± 7.8 0.006
Weight (kg), mean ± SD 50.0 ± 8.8 61.0 ± 10.2  < 0.0001
CDAI, mean ± SD 97.6 ± 59.5 93.4 ± 53.6 0.76
Disease duration (year), mean ± SD 15.9 ± 12.06 12.84 ± 8.57 0.21
CRP (mg/dL), mean ± SD 0.21 ± 0.31 0.39 ± 0.51 0.09
ALB (g/dL), mean ± SD 3.91 ± 0.56 3.92 ± 0.54 0.91
IL-6 (pg/mL), mean ± SD 2.69 ± 2.61 2.41 ± 2.07 0.6
TNF-α (pg/mL), mean ± SD 17.69 ± 20.45 28.63 ± 34.9 0.09
GDF-8 (pg/mL), mean ± SD, 4107.1 ± 1418.1 4244.9 ± 1558.2 0.7
GDF-15 (pg/mL), mean ± SD 1511.0 ± 1646.3 688.2 ± 575.3 0.013

Data was analyzed either by t test or χ2 test.

BMI body mass index, CDAI Crohn’s disease activity index, CRP C-reactive protein, ALB albumin, IL-6 Interleukin-6, TNF-α tumor necrosis factor-alpha, GDF-8 growth differentiation factor-8, GDF-15 growth differentiation factor-15, SD standard deviation, SMI skeletal muscle mass index.

Significant values are in bold.